Global At-Home Drug of Abuse (DOA) Testing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview

• 1.1 At-Home Drug of Abuse (DOA) Testing Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Test Cups
  • 1.2.2 Test Dip Cards
  • 1.2.3 Test Strips
  • 1.2.4 Others
• 1.3 Market Analysis by Applications
  • 1.3.1 Urine
  • 1.3.2 Saliva
  • 1.3.3 Hair
  • 1.3.4 Others
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2013-2023)
    • 1.4.1.2 Canada Market States and Outlook (2013-2023)
    • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2013-2023)
    • 1.4.2.2 France Market States and Outlook (2013-2023)
    • 1.4.2.3 UK Market States and Outlook (2013-2023)
    • 1.4.2.4 Russia Market States and Outlook (2013-2023)
    • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2013-2023)
    • 1.4.3.2 Japan Market States and Outlook (2013-2023)
    • 1.4.3.3 Korea Market States and Outlook (2013-2023)
    • 1.4.3.4 India Market States and Outlook (2013-2023)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
    • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
    • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 UCP Biosciences Inc.
  • 2.1.1 Business Overview
  • 2.1.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 UCP Biosciences Inc. At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.2 Orient New Life Medical Co. Ltd.
  • 2.2.1 Business Overview
  • 2.2.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Orient New Life Medical Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.3 Express Diagnostics Int’l Inc.
  • 2.3.1 Business Overview
  • 2.3.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Express Diagnostics Int’l Inc. At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.4 Assure Tech (Hangzhou) Co. Ltd.
  • 2.4.1 Business Overview
  • 2.4.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Assure Tech (Hangzhou) Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.5 Psychemedics Corporation
  • 2.5.1 Business Overview
  • 2.5.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.6 Confirm BioSciences
  • 2.6.1 Business Overview
  • 2.6.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.7 Phamatech Inc.
  • 2.7.1 Business Overview
  • 2.7.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Phamatech Inc. At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.8 Home Health (U.K.) Ltd.
  • 2.8.1 Business Overview
  • 2.8.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.9 Quest Products Inc.
  • 2.9.1 Business Overview
  • 2.9.2 At-Home Drug of Abuse (DOA) Testing Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Quest Products Inc. At-Home Drug of Abuse (DOA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

• 3.1 Global At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Manufacturer (2016-2017)
• 3.2 Global At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Manufacturer (2016-2017)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 At-Home Drug of Abuse (DOA) Testing Manufacturer Market Share in 2017
  • 3.3.2 Top 6 At-Home Drug of Abuse (DOA) Testing Manufacturer Market Share in 2017
• 3.4 Market Competition Trend

4 Global At-Home Drug of Abuse (DOA) Testing Market Analysis by Regions

• 4.1 Global At-Home Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Regions
  • 4.1.1 Global At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Regions (2013-2018)
• 4.2 North America At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 4.3 Europe At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 4.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 4.5 South America At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 4.6 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

5 North America At-Home Drug of Abuse (DOA) Testing by Countries

• 5.1 North America At-Home Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries
  • 5.1.1 North America At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)
• 5.2 United States At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 5.3 Canada At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 5.4 Mexico At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

6 Europe At-Home Drug of Abuse (DOA) Testing by Countries

• 6.1 Europe At-Home Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries
  • 6.1.1 Europe At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)
• 6.2 Germany At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 6.3 UK At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 6.4 France At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 6.5 Russia At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 6.6 Italy At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

7 Asia-Pacific At-Home Drug of Abuse (DOA) Testing by Countries

• 7.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries
  • 7.1.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)
• 7.2 China At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 7.3 Japan At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 7.4 Korea At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 7.5 India At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 7.6 Southeast Asia At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

8 South America At-Home Drug of Abuse (DOA) Testing by Countries

• 8.1 South America At-Home Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries
  • 8.1.1 South America At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)
• 8.2 Brazil At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 8.3 Argentina At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 8.4 Colombia At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

9 Middle East and Africa At-Home Drug of Abuse (DOA) Testing by Countries

• 9.1 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Countries
  • 9.1.1 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Countries (2013-2018)
• 9.2 Saudi Arabia At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 9.3 UAE At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 9.4 Egypt At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 9.5 Nigeria At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)
• 9.6 South Africa At-Home Drug of Abuse (DOA) Testing Sales and Growth Rate (2013-2018)

10 Global At-Home Drug of Abuse (DOA) Testing Market Segment by Type

• 10.1 Global At-Home Drug of Abuse (DOA) Testing Sales, Revenue and Market Share by Type (2013-2018)
  • 10.1.1 Global At-Home Drug of Abuse (DOA) Testing Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Type (2013-2018)
• 10.2 Test Cups Sales Growth and Price
  • 10.2.1 Global Test Cups Sales Growth (2013-2018)
  • 10.2.2 Global Test Cups Price (2013-2018)
• 10.3 Test Dip Cards Sales Growth and Price
  • 10.3.1 Global Test Dip Cards Sales Growth (2013-2018)
  • 10.3.2 Global Test Dip Cards Price (2013-2018)
• 10.4 Test Strips Sales Growth and Price
  • 10.4.1 Global Test Strips Sales Growth (2013-2018)
  • 10.4.2 Global Test Strips Price (2013-2018)
• 10.5 Others Sales Growth and Price
  • 10.5.1 Global Others Sales Growth (2013-2018)
  • 10.5.2 Global Others Price (2013-2018)

11 Global At-Home Drug of Abuse (DOA) Testing Market Segment by Application

• 11.1 Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Application (2013-2018)
• 11.2 Urine Sales Growth (2013-2018)
• 11.3 Saliva Sales Growth (2013-2018)
• 11.4 Hair Sales Growth (2013-2018)
• 11.5 Others Sales Growth (2013-2018)

12 At-Home Drug of Abuse (DOA) Testing Market Forecast (2018-2023)

• 12.1 Global At-Home Drug of Abuse (DOA) Testing Sales, Revenue and Growth Rate (2018-2023)
• 12.2 At-Home Drug of Abuse (DOA) Testing Market Forecast by Regions (2018-2023)
  • 12.2.1 North America At-Home Drug of Abuse (DOA) Testing Market Forecast (2018-2023)
  • 12.2.2 Europe At-Home Drug of Abuse (DOA) Testing Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Forecast (2018-2023)
  • 12.2.4 South America At-Home Drug of Abuse (DOA) Testing Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Forecast (2018-2023)
• 12.3 At-Home Drug of Abuse (DOA) Testing Market Forecast by Type (2018-2023)
  • 12.3.1 Global At-Home Drug of Abuse (DOA) Testing Sales Forecast by Type (2018-2023)
  • 12.3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share Forecast by Type (2018-2023)
• 12.4 At-Home Drug of Abuse (DOA) Testing Market Forecast by Application (2018-2023)
  • 12.4.1 Global At-Home Drug of Abuse (DOA) Testing Sales Forecast by Application (2018-2023)
  • 12.4.2 Global At-Home Drug of Abuse (DOA) Testing Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology